Drugs / Huangqi Guizhi Wuwu decoction
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT05566457 | Jan 2020 → Jan 2023 | breast cancer | Chinese Academy of Medical Sciences | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT04261920 | Jan 2020 → Jan 2023 | — | Jiangsu Famous Medical Technology Co., Ltd. | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05418465 | Jan → Dec 2022 | diabetic kidney disease | The First Affiliated Hospital of Dalian Medical University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Huangqi Guizhi Wuwu decoction | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04261920 ↗ |
| Known as | HGWD | “Huangqi Guizhi Wuwu decoction (HGWD) is an herbal formula recorded in "Synopsis of the Golden Chamber" for improving limb pain, tingling, and numbness” NCT05566457 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Huangqi Guizhi Wuwu decoction is a classical prescription of ancient Chinese medicine recorded in "the synopsis of the Golden Chamber," which can be used in the treatment of...” PMID 32481364 ↗ May 2020 |
| Route | Oral | “The experimental group took Huangqi Guizhi Wuwu decoction twice a day, infused with warm water.” NCT04261920 ↗ |